J.-P. Arnault

Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>

J.-P. Arnault, Christine Mateus, Bernard Escudier et al. · Clinical Cancer Research · 2011 · 120 citations · Full text

Medicine, Dermatology, Oncology +17

A New Spectrum of Skin Toxic Effects Associated With the Multikinase Inhibitor Vandetanib

Damien Giacchero, Constanza Fernanda Ramacciotti, J.-P. Arnault et al. · Archives of Dermatology · 2012 · 60 citations

Medicine, Oncology, Pharmacology +17

Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort

Manon Girod, Stéphane Dalle, Laurent Mortier et al. · JCO Precision Oncology · 2022 · 14 citations

Medicine, Molecular Genetics, Oncology +17

Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma

C. Mignard, A. Deschamps-Huvier, A.-B. Duval-Modeste et al. · Annals of Oncology · 2018 · 13 citations · Full text

Medicine, Dermatology, Oncology +17